BHCM
NEO icon

Boulder Hill Capital Management’s NeoGenomics NEO Stock Holding History

Boulder Hill Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-101,065
Closed -$1.76M – 150
2023
Q1 		$1.76M Buy
+101,065
New +$1.44M 1.42% 8
2022
Q1 		– Sell
-19,100
Closed -$652K – 203
2021
Q4 		$652K Buy
+19,100
New +$748K 0.63% 32

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boulder Hill Capital Management's NEO Position: Q2 2023 in Review

Boulder Hill Capital Management sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 101,065 shares — an estimated $1.76M sold.

Boulder Hill Capital Management first reported a position in NEO in Q4 2021 and held it in 2 quarters. The position peaked at $1.76M in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Boulder Hill Capital Management reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 101,065 NeoGenomics shares in Q2 2023, an estimated $1.76M.
  • Boulder Hill Capital Management first reported a position in NeoGenomics in Q4 2021 and held it in 2 quarters.
  • Boulder Hill Capital Management's NeoGenomics position peaked at $1.76M in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Boulder Hill Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.